3 IPOs That Would Soon Set The Market On Fire
There are three recent IPO stocks you should look out for.
avatar
Precious Njoku is a Financial Writer with extensive knowledge about the stock market.
2022-09-10 11:15

We all know IPO is one of the major routes companies take to enter the trading market. However, over the past few months, many investors had to pull back from investing in IPO due to the market volatility caused by inflation and the tension between the U.S and Russia, consequently decreasing the available listings on the U.S stock market.
3 IPOs That Would Soon Set The Market On Fire
Stocks on the U.S listings have never had it worse since 2009. But the good thing about IPOs is that once you get a great catch, there is potential to get quality investment returns. Experts and analysts project that 184 companies are going public this year. As an investor, you should take time to research before attempting to invest. There are three recent IPO stocks you should look out for.

These companies went public beginning the month of May and have caught my attention. You can do well to put them on your watchlist. Let's check them out.

1- ProFrac (NASDAQ: PFHC)
ProFrac (NASDAQ: PFHC) was founded less than a decade ago, around 2016. It's an energy service company providing products and services for North American oil and gas exploration and production sectors. Services provided include Hydraulic fracturing, well-completion services, and other complementary products and services.

Earlier this year, on May 13, PFHC IPO launched open and closed that day at $18.11, slightly above the $18 opening price. They have raised $441.6 million, with their shares going up to 9%. The financial report released since the company became a public entity in 2022 showed that a net income was reported at $70.1 million, a cash position of $73.7 million as of June 30, revenues coming in at $589.8 million, and a top line quarter-over-quarter gain of 40% with $88 million in total liquidity at the end of Q2.

Presently, there's a Strong Buy consensus rating for the stock. With the current trading price at $19.79 and an average price target of $26.93, an uprise of 36% will be seen in the next 12 months.

2- Hanover Bancorp (NASDAQ: HNVR)
Hanover (NASDAQ: HNVR) offers loans, mortgages, card services, and financial services to smaller customers, including retail and small business clients. These services include loans, checking and savings account, bank advisory services, mortgages and business loans, and debit cards.

Established in 2009, Hanover is worth $1.6 billion in assets and operations located in metropolitan NYC, Long Island, and New Jersey. The stock opened on May 11 to May 13 at $21; since then, the stock has only dropped by 5%.

The company ended its 3Q of the fiscal year 2022 with a net income of $5.3 million, or 80 cents per diluted share, compared to a year ago of $221,000 and 5 cents per diluted share which is substantial. A 50% revenue increase was also observed from the same period last year to $16.65 million. At the end of the year-ago quarter, the assets were $1.54 billion compared to the current $1.6 billion in assets this year, which included $133 million in cash.

Hanover (NASDAQ: HNVR) has paid three common share dividends this year in February, June, and August. The payments brought a yield of 2 %. Therefore while considering the growth potential of this stock, you can also benefit from the dividend payout.

3- PepGen (NASDAQ: PEPGEN)
PepGen (NASDAQ: PEPGEN) is a company in the biotechnology sector that manufacture new therapeutic drugs used to treat severe neuromuscular and neurological diseases. Founded in 1995, PepGen has several drugs in its discovery and preclinical trial phase. The company held its IPO in May to secure funds for the human trial phase. The initial pricing of the share was $12 on launch day, and the first day's close was $12.89. $108 million was successfully raised as expected.

However, the shares have fallen by 24% due to the massive selloff, making it cheaper and attractive for investors, if you must ask me.

I'm optimistic about this stock and give it a strong buy recommendation. The shares are currently trading at $10.72 with a $27 average target price, indicating a more than 100% upside for the coming year.

Which IPO are you looking out for currently? Please let me know in the comment section below.


Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

positive
negative
Guest
Guest
6 months ago
.
0
Guest
Guest
6 months ago
bio company founded in 95 yet not one approved drug. they are scamming on investors
0
Published On
2022-09-10 11:15

avatar
About the Author
Precious Njoku is a Financial Writer with extensive knowledge about the stock market.

buy-coffee
You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

What on Earth Happened to SVB Financial Group (SIVB)?
What is in Store for Silicon Valley Bank?
By Mike Sakuraba | 1 week ago

2 Tech Stocks to Consider for the Long Term
Even with all of the bearishness in the markets, as investors, we should be looking for quality stocks.
By Mike Sakuraba | 1 week ago

Why Tesla's Recent Event Failed to Deliver
Tesla's recent event failed to meet investors' expectations due to the lack of a Next Generation EV announcement.
By Staff | 2 weeks ago

Qualcomm's partnership with Iridium takes connectivity to new heights
Qualcomm's partnership with Iridium brings satellite-based messaging technology to phones, laptops and other devices, providing new opportunities for connectivity in any location.
By Staff | 2 months ago

Hologic's Fiscal Q1 2023 Earnings: A Ray of Hope in a Stormy Year
Hologic has managed to achieve impressive financial results in Fiscal Q1 2023.
By Staff | 2 months ago

Why Small and Mid-Cap Stocks Deserve Your Attention
Why valuations make small and mid-cap stocks an attractive option in a potential recession.
By Staff | 2 months ago

Get Ready for a Bumpy Year
Despite strong job creation numbers, deeper issues lurk beneath the surface as the Federal Reserve's rate hikes and high inflation threaten to derail the economy.
By Staff | 2 months ago